内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Apuli Maricel. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Aggregated, 13 filings have been recorded. Split: 0 buy · 5 sells. Total volume traded: €453k. History available since 19 March 2025. The latest transaction was filed on 16 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Apuli Maricel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
4,714 股@ US$79.86Common StockSEC:0001470831-26-000835:0
2,000 股@ US$80.060.0010% mcap9.4% 占其流量Common StockSEC:0001470831-26-000745:0
14,170 股0Common StockSEC:0001470831-26-000302:0
2,000 股@ US$66.008.3% 占其流量Common StockSEC:0001470831-26-000225:0
4,349 股@ US$75.2520.5% 占其流量Common StockSEC:0001470831-26-000186:0
2,003 股@ US$75.1516.2% 占其流量Common StockSEC:0001470831-25-000418:0
2,000 股@ US$74.2613.3% 占其流量Common StockSEC:0001470831-25-000392:0
4,781 股@ US$66.3934.5% 占其流量Common StockSEC:0001470831-25-000349:0
4,781 股@ US$51.3226.6% 占其流量Common StockSEC:0000950170-25-110276:0
1,000 股@ US$45.444.7% 占其流量Common StockSEC:0000950170-25-106751:0
4,780 股@ US$33.8418.3% 占其流量Common StockSEC:0000950170-25-075340:0
1,026 股@ US$38.50794.4% 占其流量Common StockSEC:0000950170-25-064567:0
23,660 股0Common StockSEC:0000950170-25-043376:0
About Apuli Maricel
Apuli Maricel is a declarant associated with BridgeBio Pharma, Inc., where the listed role is Chief Accounting Officer. There are 12 filings in total, and across the 12 sampled filings between 2025-03-21 and 2026-08-03, sell volume totals EUR 452908 and the modal transaction nature is Sale.